Navigation Links
Support cells, not neurons, lull the brain to sleep
Date:1/28/2009

n shown to influence behavior. Unlike neurons, astrocytes do not fire electrical spikes, and they are often described as support cells.

In experiments on mice, Dr. Halassa and his colleagues used a genetic switch, called the dnSNARE transgene, to block the release of adenosine and other chemicals from astrocytes. The researchers then deprived the mice of sleep for short periods, and evaluated them with behavioral tests and with electroencephalography (EEG), a means of recording brain activity.

Mice subjected to the genetic blockade exhibited less sleep pressure than control mice. Following sleep deprivation, they did not need as much compensatory sleep, and during the early phases of sleep, they had patterns of brain activity consistent with low sleep pressure. When they were evaluated with a memory test, they performed as if their sleep had been undisturbed.

The researchers observed similar results when they used certain compounds to block the effects of adenosine on neurons. Neurons have several types of cell-surface receptors that enable them to respond to adenosine, but only pharmacological blockade of the A1 type of receptor was effective. That result shows that adenosine acts through the A1 receptor to produce sleep pressure.

Taken together, the results hint at the possibility of new drugs that could increase or decrease sleep pressure as necessary. The best available sleep aids tend to be effective at inducing sleep, but not effective at keeping it steady throughout the night. Meanwhile, the most commonly used stimulant, caffeine, acts on multiple types of adenosine receptors, and can affect sleep patterns even when it is consumed in the morning. Drugs that target astrocytes or the A1 receptors on neurons might be more effective at fine-tuning the urge to sleep, the study authors say.

The dnSNARE mice also will prove useful for answering some long-standing questions about sleep, experts say. For instanc
'/>"/>

Contact: Daniel Stimson
stimsond@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Purkinje Announces EMR Promotions in Support of National Healthcare Reform Initiatives
2. Call- Shadow IP Call Management Software, V.5. Now 64 bit with SIP and Enhanced Platform Support
3. Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education
4. Lance Armstrong Foundation Selects Ogilvy Public Relations Worldwide to Support the LIVESTRONG Global Cancer Campaign
5. Impac Software Announces Clinical Release of RapidArc Support
6. Technology Leaders Call on Congress to Support Investments in Digital Infrastructure as Part of Economic Stimulus and Recovery Plan
7. Grassroots Group Gets Travel Advantage Network Support
8. Developing countries need support to ethically conduct unlinked anonymous HIV testing
9. The Quantum Group Announces Support of Technology Bill Before Congress
10. Seattle Reproductive Medicine Study Investigates Newly Formulated Medications for Luteal Support in IVF
11. National Council of Legislators From Gaming States Adopts Resolution Supporting 100% Smokefree Gaming Venues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... IL (PRWEB) , ... July 31, 2015 , ... The ... Boston, when Major League Baseball and the Boston Red Sox honor Ice Bucket co-founders ... the challenge. MLB is donating $100,000 to further collaborative efforts among the ALS organizations ...
(Date:7/31/2015)... ... July 31, 2015 , ... Successful Import/Export Programs:, ... http://www.fdanews.com/importexportprogram , Having FDA-regulated products held at ports costs time, money and ... containment — or even destruction — of products, an FDA insider shows manufacturers ...
(Date:7/31/2015)... ... July 31, 2015 , ... Burnaby ... post that encourages the understanding and treatment of ankle sprains. A common sports ... remedies. This can be dangerous if the condition augments and causes more disruption. ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... proud to announce that their latest designer handbag line will be named for ... an Internet sensation as the first globally recognized model with Down syndrome, gracing ...
(Date:7/31/2015)... ... July 31, 2015 , ... Eldermark ... for LeadingAge’s Center for Aging Services Technologies (CAST) Medication Management Technologies whitepaper. The ... post-acute care providers understand the benefits of using medication management technologies . ...
Breaking Medicine News(10 mins):Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 4Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 2Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 4Health News:Absolute PhysioCare & Sports Rehab Promotes Understanding & Treatment of Ankle Sprains 2Health News:everMaya to Launch Madeline Stuart Handbag Line 2Health News:everMaya to Launch Madeline Stuart Handbag Line 3Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3
... The following is a,statement by Bonnie J. Campbell, ... jury unanimously concluded that former manufacturers,of lead pigment used ... the,harm claimed by this plaintiff. The jury unanimously found ... paint., "Under Wisconsin law, property owners are legally ...
... Rhythm Congress 2007 ... Live EP Cases in Birmingham, UK, CARLSBAD, ... company, announced today its successful first,public broadcast of a procedure ... by Dr. Lucas Boersma of the St. Antonius,Hospital in Nieuwegein, ...
... five treated babies doesn,t have excess stomach acid, study ... may be overprescribing anti-reflux medications to infants, new research ... in five babies given anti-reflux medications, which work by ... levels. That means four out of five infants included ...
... of choice to manage abnormal heart rhythms, a new ... School of Medicine suggests that women with ICDs fare ... retrospective analysis to be presented at the AHA Scientific ... p.m.), lead researcher Andrea Russo, M.D., Clinical Associate Professor ...
... Guatemala, Nov. 5 World-renowned heart,surgeon Dr. Rafael Espada ... President of Guatemala. President-elect Alvaro Colom, with Dr.,Espada as ... than 52.8 percent of the country,s votes. The two ... Guatemala, Dr. Espada has practiced for more than 30 ...
... Nov. 5 Lincoln Financial,Advisors, part of ... announced today that it has entered into ... to provide its members access to,services provided ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050830/LFLOGO ) ...
Cached Medicine News:Health News:First in the World Live Case Using New Technology Demonstrates Shorter Procedure Time 2Health News:First in the World Live Case Using New Technology Demonstrates Shorter Procedure Time 3Health News:Anti-Reflux Drugs May Be Overprescribed in Infants 2Health News:Anti-Reflux Drugs May Be Overprescribed in Infants 3Health News:Do women fare worse with some heart devices? 2Health News:Houston Heart Surgeon Elected Vice President of Guatemala 2Health News:Lincoln Financial Advisors to Provide Exclusive Services to American Osteopathic Association Members 2Health News:Lincoln Financial Advisors to Provide Exclusive Services to American Osteopathic Association Members 3
(Date:7/30/2015)... July 30, 2015  Today we bring you a special edition of #MedicareMonday on ... you about some of our Medicare resources and continue highlighting the success of the ... Check out our latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
(Date:7/30/2015)... 2015 PTC Therapeutics, Inc. (NASDAQ: PTCT ... results for the second quarter ending June 30, 2015. ... across the organization.  We are excited to be near ... trial ever conducted with topline results expected in the ... Officer, PTC Therapeutics, Inc. "Translarna is now commercially available ...
(Date:7/30/2015)... 2015 Eisai Inc. announced today that regulatory ... States , European Union and Japan ... for eribulin, for the treatment of patients with inoperable ... for advanced or metastatic disease. These ... global Phase 3 clinical trial (Study 309), which met ...
Breaking Medicine Technology:Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... HOUSTON, May 2, 2011 Otto Kaiser Memorial Hospital ... in favor of ChartAccess® Comprehensive EHR from Prognosis Health ... 25-bed hospital comply with the federal government,s meaningful use ... health information organization (RHIO). "We,re known ...
... N.Y., May 2, 2011 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... America Merrill Lynch 2011 Health Care Conference on Tuesday, May ... Time).  The session may be accessed through the Company,s web ... archived version of the presentation will be available after the ...
Cached Medicine Technology:Otto Kaiser Memorial Hospital Turns to Prognosis ChartAccess® Comprehensive EHR to Meet Organizational Aspirations 2Otto Kaiser Memorial Hospital Turns to Prognosis ChartAccess® Comprehensive EHR to Meet Organizational Aspirations 3
... OraQuick is an FDA ... venipuncture whole blood test used ... of HIV-1 infection. This CLIA ... presence of antibodies to HIV-1, ...
... Mononucleosis test is designed to detect ... plasma or whole blood. The QuickVue+ ... of bovine erythrocytes which give a ... extracts prepared from sheep and horse ...
... available point-of-care diagnostic test that can reliably ... A and B. The test uses a ... that assists viral replication by promoting the ... The ZstatFlu substrate is labeled with a ...
The NOW Flu A test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results and tre...
Medicine Products: